BioSpace News Archive

Dr. Jason Gallagher discusses the responsibility of medical professionals to educate the community

Schubert Jonckheer & Kolbe LLP is investigating whether certain directors and officers of MiMedx Group, Inc. breached their fiduciary duties by causing the Company to engage in accounting manipulation and issue false and misleading statements to shareholders and the market.

On Aug. 3, the U.S. Food and Drug Administration will be hosting a public advisory committee meeting to review data from the most recent assessment of the Risk Evaluation and Mitigation Strategy (REMS) with Elements to Assure Safe Use (ETASU) for transmucosal immediate-release fentanyl (TIRF) products.

Biotest Pharmaceuticals Corporation (BPC), a wholly owned subsidiary of Biotest US Corporation (“Biotest USA”), and a leader in the collection of Source Plasma, is pleased to announce that Grifols Shared Services North America, Inc., a wholly owned subsidiary of Grifols, S.A. has completed its acquisition of Biotest USA for $286 Million in cash.

PepVax, Inc.., an early-stage biotechnology company, announced today the launch of its novel SMARTmid™ platform for drug delivery of nucleic acid and amino acid-based drugs and cell therapies in pre-clinical development.

Rehabilitation games for stroke recovery capture international attention and acclaim

Study Provides Insight into How Sex Cells Fail, And How One Species Becomes Two

One source for oral health and voluntary benefits enrollment simplifies the experience for employers and their employees

Natera, Inc., (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its second quarter ended June 30, 2018, after the market close on Aug. 8, 2018.

Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth